Alloplex Biotherapeutics: Funding, Investors & Team (Oct 2026)
In order to create a potent anti-tumor vaccination, Alloplex Biotherapeutics is committed to examining the higher order combinatorial space of immunomodulators. This method works with all tumour types and is especially well-suited for use in conjunction with checkpoint inhibitors. Private startup Alloplex is currently funded by angel financing.
Alloplex Biotherapeutics has raised $21.0M across 2 funding rounds on record, the most recent a Series A of $20.0M announced in Feb 2023.
That round is above the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Alloplex Biotherapeutics Company Profile and Key Stats
Latest funding round on record: Feb 2023.
Alloplex Biotherapeutics Funding Rounds
Alloplex Biotherapeutics raised $1.0M in a Corporate Round announced in Aug 2021.
1.5 years later, a Series A of $20.0M was announced in Feb 2023.
Alloplex Biotherapeutics Founders and Leadership Team
Contact details for the Alloplex Biotherapeutics team: 1 of 1 has an email address on file.
Start 14-day free trial →Alloplex Biotherapeutics Funding Compared to Other Biotechnology Startups
Alloplex Biotherapeutics' latest round of $20.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Alloplex Biotherapeutics in Biotechnology and Boston
Companies Similar to Alloplex Biotherapeutics
Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…
Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Alloplex Biotherapeutics Funding FAQs
What does Alloplex Biotherapeutics do?
In order to create a potent anti-tumor vaccination, Alloplex Biotherapeutics is committed to examining the higher order combinatorial space of immunomodulators. This method works with all tumour types and is especially well-suited for use in conjunction with checkpoint inhibitors. Private startup Alloplex is currently funded by angel financing.
How much funding has Alloplex Biotherapeutics raised?
Alloplex Biotherapeutics has raised $21.0M across 2 rounds on record. The most recent is a Series A of $20.0M announced in Feb 2023.
When did Alloplex Biotherapeutics last raise funding?
Alloplex Biotherapeutics' most recent funding round on record is a Series A of $20.0M, announced in Feb 2023.
Who is the CEO of Alloplex Biotherapeutics?
Frank Borriello is listed as CEO at Alloplex Biotherapeutics.
Where is Alloplex Biotherapeutics headquartered?
Alloplex Biotherapeutics is based in Boston, Massachusetts, United States.
How many employees does Alloplex Biotherapeutics have?
Alloplex Biotherapeutics is in the 1-10 employee band.
How does Alloplex Biotherapeutics' funding compare to other Biotechnology startups?
Alloplex Biotherapeutics' latest round of $20.0M is above the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Alloplex Biotherapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Alloplex Biotherapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.